Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled TrialPeter L. Havens, James Bethel, Chi‐Feng Pan et al.|Clinical Infectious Diseases|2012Cited by 69
Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?Peter L. Havens, Kathleen Mulligan, Jennifer J. Kiser et al.|Antimicrobial Agents and Chemotherapy|2013Cited by 63
Serum 25-Hydroxyvitamin D Response to Vitamin D<sub>3</sub>Supplementation 50,000 IU Monthly in Youth with HIV-1 InfectionPeter L. Havens, and the ALSWH Research Team, Kathleen Mulligan et al.|The Journal of Clinical Endocrinology & Metabolism|2012Cited by 47
Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil FumaratePeter L. Havens, Rohan Hazra, Charles B. Stephensen et al.|Antiviral Therapy|2013Cited by 13